Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 691 AL 705

¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C.

Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.

Understanding the cognitive underpinnings of functional impairments in early dementia: a review

Giebel CM, Challis D, Montaldi D.

Aging Ment Health. 2015;19(10):859-75. doi: 10.1080/13607863.2014.1003282. Epub 2015 Jan 29.

Guidelines for dementia-related health advocacy for adults with intellectual disability and dementia: National Task Group on Intellectual Disabilities and Dementia Practices

Bishop KM, Hogan M, Janicki MP, Keller SM, Lucchino R, Mughal DT, Perkins EA, Singh BK, Service K, Wolfson S; Health Planning Work Group of National Task Group on Intellectual Disabilities and Dementia Practices.

Intellect Dev Disabil. 2015 Feb;53(1):2-29. doi: 10.1352/1934-9556-53.1.2.

[Cognitive Function and Calcium. Intake of calcium and dementia]

Otsuka M.

Clin Calcium. 2015 Feb;25(2):195-200.

Delayed diagnosis of an old Chinese woman with familial Alzheimer's disease

Shea YF, Chu LW, Chan AO, Kwan JS.

J Formos Med Assoc. 2015 Oct;114(10):1020-1. doi: 10.1016/j.jfma.2014.11.003. Epub 2015 Jan 26.

[Therapeutic massage on behavioral disturbances of elderly patients with dementia]

Barquilla Ávila C, Rodríguez-Mansilla J.

Aten Primaria. 2015 Dec;47(10):626-35. doi: 10.1016/j.aprim.2014.11.008. Epub 2015 Jan 29.

Cellular and network mechanisms underlying memory impairment induced by amyloid β protein

Salgado-Puga K, Pena-Ortega F.

Protein Pept Lett. 2015;22(4):303-21. doi: 10.2174/0929866522666150202112154.

The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease

Tang X, Holland D, Dale AM, Younes L, Miller MI; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2015 Jun;36(6):2093-117. doi: 10.1002/hbm.22758. Epub 2015 Feb 3.

Association between TNF-α promoter -308 A/G polymorphism and Alzheimer's disease: a meta-analysis

Lee YH, Choi SJ, Ji JD, Song GG.

Neurol Sci. 2015 Jun;36(6):825-32. doi: 10.1007/s10072-015-2102-8. Epub 2015 Feb 3.

Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge

Bron EE, Smits M, van der Flier WM, Vrenken H, Barkhof F, Scheltens P, Papma JM, Steketee RM, Méndez Orellana C, Meijboom R, Pinto M, Meireles JR, Garrett C, Bastos-Leite AJ, Abdulkadir A, Ronneberger O, Amoroso N, Bellotti R, Cárdenas-Peña D, Álvarez-Meza AM, Dolph CV, Iftekharuddin KM, Eskildsen SF, Coupé P, Fonov VS, Franke K, Gaser C, Ledig C, Guerrero R, Tong T, Gray KR, Moradi E, Tohka J, Routier A, Durrleman S, Sarica A, Di Fatta G, Sensi F, Chincarini A, Smith GM, Stoyanov ZV, Sørensen L, Nielsen M, Tangaro S, Inglese P, Wachinger C, Reuter M, van Swieten JC, Niessen WJ, Klein S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 May 1;111:562-79. doi: 10.1016/j.neuroimage.2015.01.048. Epub 2015 Jan 31.

Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study

Ting WK, Fischer CE, Millikin CP, Ismail Z, Chow TW, Schweizer TA.

Curr Alzheimer Res. 2015;12(2):165-72. doi: 10.2174/1567205012666150204130456.

The prevalence of depressive symptoms in frontotemporal dementia: a meta-analysis

Chakrabarty T, Sepehry AA, Jacova C, Hsiung GY.

Dement Geriatr Cogn Disord. 2015;39(5-6):257-71. doi: 10.1159/000369882. Epub 2015 Feb 4.

Age-related hearing impairment-a risk factor and frailty marker for dementia and AD

Panza F, Solfrizzi V, Logroscino G.

Nat Rev Neurol. 2015 Mar;11(3):166-75. doi: 10.1038/nrneurol.2015.12. Epub 2015 Feb 17.

Vascular risk factors and Alzheimer's disease pathogenesis: are conventional pharmacological approaches protective for cognitive decline progression?

Safouris A, Psaltopoulou T, Sergentanis TN, Boutati E, Kapaki E, Tsivgoulis G.

CNS Neurol Disord Drug Targets. 2015;14(2):257-69. doi: 10.2174/1871527314666150217123147.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias